Analytics in Support of Cell Line and Process Development Using a Single Biopharmaceutical Platform Solution

Feb 13, 2018

Register Free:

High-resolution liquid chromatography (LC) and mass spectrometry (MS) technologies are essential for protein characterization and critical product attribute profiling/monitoring during biotherapeutics/biosimilar development and manufacturing. Bioceros, a member of the Polpharma Biologics group, has in-house capacities from DNA sequence to 1000-L scale GMP production and beyond. In this webcast, Gideon Oudgenoeg and Jeroen De Keijzer will explain how Bioceros is able to use state-of-the-art UPLC–MS technologies with advanced sample prep technology to establish an in-house protein characterization platform that meets high quality standards and maintains data integrity. The audience will be guided through the Bioceros in-house process flow and the analytics that provide pivotal evaluation of each step with the analytical platforms controlled by the networked UNIFI software from Waters.


Gideon Oudgenoeg, Director Analytical Development, Bioceros

Jeroen de Keijzer, Scientist Analytical Development, Bioceros


Date and Time:

Live: Tuesday, 13 Feb., 2018 | 10 am EST | 9 am CST | 7 am PST | 1600 GMT | 1700 CET

After the final airing of the webcast on 13 Feb., 2018 it will be available on demand until 13 Feb., 2019. 

Sponsor: Waters Corporation

Register Free:

lorem ipsum